Gaili Ji

587 total citations
17 papers, 179 citations indexed

About

Gaili Ji is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Gaili Ji has authored 17 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Gaili Ji's work include RNA Interference and Gene Delivery (3 papers), MicroRNA in disease regulation (3 papers) and Cancer Research and Treatments (2 papers). Gaili Ji is often cited by papers focused on RNA Interference and Gene Delivery (3 papers), MicroRNA in disease regulation (3 papers) and Cancer Research and Treatments (2 papers). Gaili Ji collaborates with scholars based in China and United States. Gaili Ji's co-authors include Zhongwei Cao, Yutian Chen, Bi‐Sen Ding, Shahin Rafii, Feifei Na, Vivek Mittal, Koji Shido, Lin Luo, Fernando J. Martínez and Tinghong Ye and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Nature Cell Biology.

In The Last Decade

Gaili Ji

15 papers receiving 176 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gaili Ji China	7	73	43	38	36	34	17	179
Hiroaki Kanzaki Japan	7	76 1.0×	38 0.9×	44 1.2×	17 0.5×	13 0.4×	19	164
Ergang Wang United States	7	65 0.9×	16 0.4×	33 0.9×	9 0.3×	32 0.9×	9	181
Qijing Wang China	10	140 1.9×	29 0.7×	53 1.4×	10 0.3×	56 1.6×	11	217
Ruoyang Shao China	6	96 1.3×	14 0.3×	27 0.7×	17 0.5×	77 2.3×	13	206
María José Paúles Spain	6	53 0.7×	34 0.8×	39 1.0×	30 0.8×	29 0.9×	14	198
Jaymie Siqi Lin Singapore	7	185 2.5×	13 0.3×	52 1.4×	38 1.1×	16 0.5×	8	237
Yu Muta Japan	7	76 1.0×	38 0.9×	22 0.6×	41 1.1×	13 0.4×	23	181
Chengjun Sun China	12	240 3.3×	68 1.6×	157 4.1×	32 0.9×	14 0.4×	18	321
Hiromi Chikada Japan	8	173 2.4×	21 0.5×	46 1.2×	99 2.8×	12 0.4×	12	302

Countries citing papers authored by Gaili Ji

Since Specialization

Citations

This map shows the geographic impact of Gaili Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaili Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaili Ji more than expected).

Fields of papers citing papers by Gaili Ji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaili Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaili Ji. The network helps show where Gaili Ji may publish in the future.

Co-authorship network of co-authors of Gaili Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Gaili Ji. A scholar is included among the top collaborators of Gaili Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaili Ji. Gaili Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ji, Gaili, et al.. (2025). Design, pharmacology, and toxicology of a novel chemically modified siRNA targeting hepatic angiotensinogen. Molecular Therapy — Nucleic Acids. 36(2). 102542–102542. 3 indexed citations

Li, Xiao-Xue, Gaili Ji, Wei Luo, et al.. (2025). MLKL PARylation in the endothelial niche triggers angiocrine necroptosis to evade cancer immunosurveillance and chemotherapy. Nature Cell Biology. 27(9). 1526–1542. 1 indexed citations

Yan, Mengli, Jing Zhang, Gaili Ji, Xiaobin Fang, & Chunheng Mo. (2025). Ferroptosis in Pneumoconiosis: From Molecular and Cellular Mechanisms to Therapeutic Strategies. SHILAP Revista de lepidopterología. 1(2). 239–256. 1 indexed citations

Huang, Z. Maggie, Shuo Yang, Gaili Ji, et al.. (2025). Design and systematic evaluation of novel chemical modification patterns enable the identification of a potent siRNA targeting PCSK9. Molecular Therapy — Methods & Clinical Development. 33(4). 101609–101609. 1 indexed citations

Yang, Yang, et al.. (2025). An RNA interference therapeutic potentially achieves functional cure of chronic hepatitis B virus infection. Nature Communications. 17(1). 179–179. 1 indexed citations

Li, Zhaolong, et al.. (2025). Ribofuranose-based GalNAc-conjugated siRNA enhances the liver-targeted delivery and elicits robust RNAi-mediated gene silencing. Molecular Therapy — Nucleic Acids. 37(1). 102801–102801.

Wang, Ya-Ping, Caixia Ma, Xiabing Li, et al.. (2025). Unraveling the role of M2 TAMs in ovarian cancer dynamics: a systematic review. Journal of Translational Medicine. 23(1). 623–623. 2 indexed citations

Kang, Luyao, et al.. (2024). Screening of prognostic factors and survival analysis based on histological type for perimenopausal endometrial carcinoma treated with hysterectomy. Discover Oncology. 15(1). 518–518.

Zhu, Hong, Yaping Wang, Yu Zhang, et al.. (2024). Overexpression of C1orf74 predicts poor outcome and promote cervical cancer progression. Heliyon. 10(24). e40966–e40966. 1 indexed citations

10.

Chen, Yutian, Zhen Li, Gaili Ji, et al.. (2024). Lung regeneration: diverse cell types and the therapeutic potential. SHILAP Revista de lepidopterología. 5(2). e494–e494. 15 indexed citations

11.

Ji, Gaili, Qiqi Li, Lin Xu, et al.. (2021). Eradication of large established tumors by drug-loaded bacterial particles via a neutrophil-mediated mechanism. Journal of Controlled Release. 334. 52–63. 2 indexed citations

12.

Guo, Fengzhu, Gaili Ji, Qiqi Li, et al.. (2019). Bacterial particles retard tumor growth as a novel vascular disrupting agent. Biomedicine & Pharmacotherapy. 122. 109757–109757. 8 indexed citations

13.

Feng, Shu, Gaili Ji, Jie Ma, et al.. (2019). Long noncoding RNA GAS5 does not regulate HBV replication. Journal of Medical Virology. 91(11). 1949–1959. 6 indexed citations

14.

Wang, Zhonghao, Gaili Ji, Qian Wu, et al.. (2018). Integrated microarray meta-analysis identifies miRNA-27a as an oncogene in ovarian cancer by inhibiting FOXO1. Life Sciences. 210. 263–270. 23 indexed citations

15.

Yang, Yun, Bei Cai, Hui Luo, et al.. (2017). Mitochondrial C11orf83 is a potent Antiviral Protein Independent of interferon production. Scientific Reports. 7(1). 44303–44303. 7 indexed citations

16.

Cao, Zhongwei, Tinghong Ye, Gaili Ji, et al.. (2017). Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis. Science Translational Medicine. 9(405). 94 indexed citations

17.

Zhao, Chengjian, Wei Zhang, Yuwei Zhao, et al.. (2016). Endothelial Cords Promote Tumor Initial Growth prior to Vascular Function through a Paracrine Mechanism. Scientific Reports. 6(1). 19404–19404. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact